Gilead Sciences Stock Price on December 13, 2024

GILD Stock  USD 91.86  0.25  0.27%   
Below is the normalized historical share price chart for Gilead Sciences extending back to January 22, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gilead Sciences stands at 91.86, as last reported on the 14th of December 2024, with the highest price reaching 92.11 and the lowest price hitting 89.15 during the day.
IPO Date
22nd of January 1992
200 Day MA
76.3107
50 Day MA
89.4962
Beta
0.192
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Gilead Stock, it is important to understand the factors that can impact its price. At this point, Gilead Sciences is very steady. Gilead Sciences holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Gilead Sciences, which you can use to evaluate the volatility of the firm. Please check out Gilead Sciences' Risk Adjusted Performance of 0.0984, market risk adjusted performance of 0.3437, and Downside Deviation of 1.51 to validate if the risk estimate we provide is consistent with the expected return of 0.17%.
  
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 65.2 B, whereas Capital Stock is forecasted to decline to about 901 K. . At present, Gilead Sciences' Price Book Value Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.80, whereas Price To Sales Ratio is forecasted to decline to 3.54. Gilead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1208

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGILD
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.42
  actual daily
12
88% of assets are more volatile

Expected Return

 0.17
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Gilead Sciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding it to a well-diversified portfolio.
Price Book
6.232
Enterprise Value Ebitda
34.0332
Price Sales
4.0684
Shares Float
1.2 B
Dividend Share
3.06

Gilead Sciences Main Headline on 13th of December 2024

Kyverna Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the recent appointments of Dan Maziasz as Chief Business Officer, Cara Bauer as Chief Human Resources Officer, and Tracy Rossin as Senior Vice President of Corporate Affairs, Communications and Investor Relations.

Gilead Sciences Valuation on December 13, 2024

It is possible to determine the worth of Gilead Sciences on a given historical date. On December 13, 2024 Gilead was worth 91.66 at the beginning of the trading date compared to the closed value of 91.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gilead Sciences stock. Still, in general, we apply an absolute valuation method to find Gilead Sciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gilead Sciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gilead Sciences' related companies.
 Open High Low Close Volume
  91.69    92.44    90.68    91.61    5,782,700  
12/13/2024
  91.66    92.11    89.15    91.86    7,514,700  
Backtest Gilead Sciences  |  Gilead Sciences History  |  Gilead Sciences Valuation Previous
Open Value
91.66
91.86
Closing Value
95.93
Upside

Gilead Sciences Trading Date Momentum on December 13, 2024

On December 13 2024 Gilead Sciences was traded for  91.86  at the closing time. The top price for the day was 92.11  and the lowest listed price was  89.15 . The trading volume for the day was 7.5 M. The trading history from December 13, 2024 did not cause price change. The overall trading delta against the current closing price is 0.22% .
JavaScript chart by amCharts 3.21.1512/13/2024Dec 03Dec 05Dec 07Dec 09Dec 11Dec 1390.090.591.091.592.092.5

Gilead Sciences Fundamentals Correlations and Trends

By evaluating Gilead Sciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gilead Sciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gilead financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Gilead Sciences Stock history

Gilead Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gilead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gilead Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gilead Sciences stock prices may prove useful in developing a viable investing in Gilead Sciences
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.3 B1.5 B
Net Income Applicable To Common Shares5.3 B4.9 B

Gilead Sciences Quarterly Net Working Capital

3.06 Billion

Gilead Sciences Stock Technical Analysis

Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Gilead Sciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Gilead Sciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Gilead Sciences Period Price Range

Low
December 14, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Gilead Sciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Gilead Sciences December 14, 2024 Market Strength

Market strength indicators help investors to evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gilead Sciences shares will generate the highest return on investment. By undertsting and applying Gilead Sciences stock market strength indicators, traders can identify Gilead Sciences entry and exit signals to maximize returns

Gilead Sciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Gilead Sciences' price direction in advance. Along with the technical and fundamental analysis of Gilead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gilead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities